MeSH term | MeSH ID | Detail |
---|---|---|
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Archer DF et al. | Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive. | 2013 | Obstet Gynecol | pmid:23921878 |
Wistuba J et al. | Experimental endocrine manipulation by contraceptive regimen in the male marmoset (Callithrix jacchus). | 2013 | Reproduction | pmid:23431271 |
Tomasicchio M et al. | The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. | 2013 | PLoS ONE | pmid:23658782 |
Chen FP et al. | Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors. | 2013 | Taiwan J Obstet Gynecol | pmid:24075375 |
Crean CS et al. | The effect of ezogabine on the pharmacokinetics of an oral contraceptive agent. | 2013 | Int J Clin Pharmacol Ther | pmid:24040852 |
Cheng G et al. | Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women. | 2013 | Menopause | pmid:23615640 |
Neubauer H et al. | Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. | 2013 | Menopause | pmid:23615641 |
Vercellini P et al. | Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life. | 2013 | Hum. Reprod. | pmid:23442755 |
Roach RE et al. | The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. | 2013 | J. Thromb. Haemost. | pmid:23136837 |
Mackay L et al. | Hormone replacement therapy for women with type 1 diabetes mellitus. | 2013 | Cochrane Database Syst Rev | pmid:23744560 |